Synthesis, characterization, and anti-melanoma activity of tetra-O-substituted analogs of nordihydroguaiaretic acid. - Test2 - elhamkhani - TriplyDB

Synthesis, characterization, and anti-melanoma activity of tetra-O-substituted analogs of nordihydroguaiaretic acid.

Synthesis, characterization, and anti-melanoma activity of tetra-O-substituted analogs of nordihydroguaiaretic acid.

http://www.wikidata.org/entity/Q37394029

about

5-lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapy Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update.Phase I study of terameprocol in patients with recurrent high-grade glioma.Interventions to Slow Aging in Humans: Are We Ready?Nordihydroguaiaretic Acid Extends the Lifespan of Drosophila and Mice, Increases Mortality-Related Tumors and Hemorrhagic Diathesis, and Alters Energy Homeostasis in Mice.Tetra-O-methyl nordihydroguaiaretic acid, an inhibitor of Sp1-mediated survivin transcription, induces apoptosis and acts synergistically with chemo-radiotherapy in glioblastoma cells.Nordihydroguaiaretic acid inhibits growth of cervical cancer SiHa cells by up-regulating p21.Characterization of Phase I and Phase II Hepatic Metabolism and Reactive Intermediates of Larrea nitida Cav. and Its Lignan Compounds.Development of nordihydroguaiaretic acid derivatives as potential multidrug-resistant selective agents for cancer treatment

P2860

Q28292415-29C6EF28-DCF8-414C-96A3-C6BCA4CEABE4 Q34081291-AF3871C9-6DF3-4C9A-9DB2-FF10D1393094 Q35845214-A9631257-7A0E-4731-A950-BF123BFBBD9B Q35935123-C0D798D0-900C-4215-9447-935903BAF109 Q36243410-9A46E4F2-49AF-4023-839A-A602DB5BBA29 Q39214188-68DFFDC4-AEF7-4992-9818-F8F3CF707580 Q41823710-9312CB2F-949F-4782-8744-4CE1B0F62229 Q48088971-163CBF83-93E6-46B4-AA1A-E309502C0278 Q57084519-A68247E0-25BF-4194-A0EF-969CA578F2C2

P2860

Synthesis, characterization, and anti-melanoma activity of tetra-O-substituted analogs of nordihydroguaiaretic acid.

http://www.wikidata.org/entity/Q37394029

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Synthesis, characterization, a ...... of nordihydroguaiaretic acid.

@en

Synthesis, characterization, a ...... of nordihydroguaiaretic acid.

@nl

type

label

Synthesis, characterization, a ...... of nordihydroguaiaretic acid.

@en

Synthesis, characterization, a ...... of nordihydroguaiaretic acid.

@nl

prefLabel

Synthesis, characterization, a ...... of nordihydroguaiaretic acid.

@en

Synthesis, characterization, a ...... of nordihydroguaiaretic acid.

@nl

P1433

Q37394029-BFFEE5B6-2B2B-4EF3-BECA-7CDC3448B7BE

P1476

Q37394029-C903CB15-5647-4F60-B98F-832FA1206D64

P2093

Q37394029-025F6A82-A7F5-4781-B88F-539B919CF05C

Q37394029-0540AFB0-4DAE-411B-BD49-389FE327CE8E

Q37394029-1A98579A-BB2E-4C4D-81A3-58F88C1DB153

Q37394029-88D9BBA7-D067-4A59-BD92-EFE907B9A64E

Q37394029-C013FBDD-8076-4F9B-BF85-67105E302763

Q37394029-D0C080B7-FC00-4A57-BD16-F3B5279B8918

P2860

Q37394029-0EE197CD-EA1F-4C99-8499-45F64FB2D843

Q37394029-14E1DC16-BE78-4F3B-99EC-8F757D7ACD2C

Q37394029-15D867A4-2D0C-4C29-812A-54E441CF083E

Q37394029-27D7B29E-A96C-41E7-8B5A-0361CCD07A14

Q37394029-2CBFC52C-ABE2-43D0-A594-5C7AFF328B44

Q37394029-4C7D8D8D-F634-4A46-A2CD-B5DC98E58197

Q37394029-520C0213-A652-4B29-BF20-4EBDFB13D111

Q37394029-560E8594-EE96-4CC1-A7DD-FD58FDEF2BE4

Q37394029-5692C75D-DA70-4EB6-8105-A2EBFE616DF8

Q37394029-7AC14C0F-3AFF-4C55-8A1B-10BC6B2CE089

P304

Q37394029-77537BE0-2415-4219-9B9F-ED9D171EA8DA

P31

Q37394029-C0007095-C13C-4426-BA69-35EBD447E949

P356

Q37394029-8D33F50F-13F9-4E78-B3CF-EDF74F00C618

P407

Q37394029-CA9FE651-AFDC-4C03-B34D-9EC43BDB8E4C

P433

Q37394029-D2E8239B-D50A-49C8-8CEB-36579F0A9629

P478

Q37394029-DB6FDC57-5D41-4BC2-84EB-F750714E9918

P577

Q37394029-2FF5D3F7-BDA2-46F6-B068-2755FC7D3B8F

P5875

Q37394029-16900242-A65A-44AF-9406-49A4CF2CD63E

P698

Q37394029-B3C33F88-B6EF-4E1A-9D36-793B6A6AE139

P932

Q37394029-1D9D1513-2304-44FE-AAD4-ACDBFD9B368A

P356

J.BMCL.2009.06.063

P1433

Bioorganic & Medicinal Chemistry Letters

P1476

Synthesis, characterization, a ...... of nordihydroguaiaretic acid.

@en

P2093

Alan Pourpak

http://www.w3.org/2001/XMLSchema#string

John A Kalaitzis

http://www.w3.org/2001/XMLSchema#string

Joshua D Lambert

http://www.w3.org/2001/XMLSchema#string

Nicole Hajicek

http://www.w3.org/2001/XMLSchema#string

Robert T Dorr

http://www.w3.org/2001/XMLSchema#string

Ross O Meyers

http://www.w3.org/2001/XMLSchema#string

P2860

Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling

Inhibition of human immunodeficiency virus type 1 transcription and replication by DNA sequence-selective plant lignans

Nordihydroguaiaretic acid: hepatotoxicity and detoxification in the mouse.

Mechanisms of nordihydroguaiaretic acid-induced growth inhibition and apoptosis in human cancer cells

In vitro cytotoxicity and DNA damage production in Chinese hamster ovary cells and topoisomerase II inhibition by 2-[2'-(dimethylamino)ethyl]-1, 2-dihydro-3H-dibenz[de,h]isoquinoline-1,3-diones with substitutions at the 6 and 7 positions (azonafides

Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression.

Systemic treatment with tetra-O-methyl nordihydroguaiaretic acid suppresses the growth of human xenograft tumors.

Tetra-O-methyl nordihydroguaiaretic acid induces G2 arrest in mammalian cells and exhibits tumoricidal activity in vivo.

Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.

Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth.

P304

4752-4755

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BMCL.2009.06.063

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26679748

http://www.w3.org/2001/XMLSchema#string

P698

19615898

http://www.w3.org/2001/XMLSchema#string

P932

2764744

http://www.w3.org/2001/XMLSchema#string